Eli Hazum

Eli Hazum

Director Técnico/Científico/I+D en
Medica Venture Partners
.
78 años
Health Technology
Consumer Services
Finance

Perfil

Eli Hazum is currently General Partner, Partner, and CSO at Medica Venture Partners since 1995.
Former roles include Chief Executive Officer at Regentis Biomaterials Ltd. from 2021 to 2025, Chief Executive Officer at Ester Neurosciences Ltd., Chief Executive Officer and Director at Collgard Biopharmaceuticals Ltd., Director and Chief Technology Officer at PRF Technologies Ltd. from 2020 to 2025, Vice President-Research & Development at Peptor Ltd, Principal at Biotechnology General (Israel) Ltd., Head-Receptor Research & Metabolic Diseases at Research Triangle Foundation, and Head-Receptor Research & Metabolic Diseases at Glaxo, Inc. from 1988 to 1992.
Education includes undergraduate and graduate degrees from Tel-Aviv University, a doctorate from Weizmann Institute of Science conferred in 1978, and an MBA from Humberside University.

Cargos activos de Eli Hazum

EmpresasCargoInicio
Director Técnico/Científico/I+D 01/01/1995

Antiguos cargos conocidos de Eli Hazum.

EmpresasCargoFin
REGENTIS BIOMATERIALS LTD. Director Ejecutivo 31/12/2025
PRF TECHNOLOGIES LTD. Director Ejecutivo 23/11/2020
Glaxo, Inc.
Corporate Officer/Principal 01/01/1992
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Eli Hazum.

Formación de Eli Hazum.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

22

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Consumer Services

Finance

Consumer Services

Commercial Services

Health Technology

Health Technology

Glaxo, Inc.

Health Technology

Health Technology

Health Technology

Consumer Services